Blood cancers

ON DEMAND: Embracing the new normal – MSAG presents the 2022 Myeloma Clinical Practice Guideline

Thursday, 12 May 2022


Watch again as an expert panel present a series of cases that explore and explain the new myeloma clinical guideline and the implications for haematologists and people living with myeloma. Developed in partnership with Myeloma Australia’s Medical and Scientific Advisory Group (MSAG), this hybrid event offered live and virtual audiences the chance to take part in group problem solving as cases were presented.

Hosted by Professor Hang Quach

Director of Clinical Haematology Service and Clinical Haematology Research, St Vincent’s Hospital and University of Melbourne; Co-Chair, Myeloma Working Group ALLG; Vice-chair, Myeloma Scientific Advisory Group, Myeloma Australia.

PANEL
Dr. Simon Gibbs.
Consultant Haematologist at Eastern Health, Alfred Health and Precision Haematology.

Dr. Anna Kalff. Consultant Clinical and Laboratory Haematologist, The Alfred Hospital, Melbourne.

Emma-Jane Furphy. Myeloma Nurse Consultant, Peter MacCallum Cancer Centre; Senior Myeloma Nurse and Special Projects, Myeloma Australia.

Prof Simon Harrison. Haematologist and Clinician Scientist, Sir Peter MacCallum Department of Oncology, University of Melbourne; Director of the Centre of Excellence in Cellular Immunotherapy, Peter MacCallum Cancer Centre; Chair of the Myeloma Scientific and Advisory group (MSAG), Myeloma Australia.

Thankyou to our sponsors

This event was supported by non restricted educational grants and created independently by the limbic in collaboration with MSAG, the host and presenters. All studies were selected by the presenters, and all views expressed are those of the host and presenters only.

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2022 the limbic